Abbott (NYSE:ABT) today shared that it made its Lingo biowearable device available for purchase at Walmart stores.

Glaukos (NYSE:GKOS) announced today that the FDA approved its Epoxia incision-free alternative to corneal cross-linking ...

Abbott continues to get a boost in its Medical Devices business from its Diabetes unit's portfolio of continuous glucose ...

Civica announced today that it plans to launch an affordable long-acting insulin in pre-filled pens starting in January 2026.

A class action lawsuit has been filed against Dexcom (Nasdaq:DXCM) in the U.S. District Court for the Central District of California.

Investors have filed a lawsuit claiming Baxter (NYSE:BAX) violated federal securities laws as a result of issues with certain infusion pumps. Bloomberg Law first reported the filing of the lawsuit in ...

The t:slim X2 system (left) and FreeStyle Libre 3 (right). [Images courtesy of Tandem Diabetes Care and Abbott] On social media, Tandem Diabetes Care (Nasdaq:TNDM) said the launch of a new integration ...